Ivan has an extensive knowledgebase in chemical biology and proteomics and a comprehensive understanding of their utility and application in drug discovery.

Benjamin Ruprecht, Ivan Cornella-Taracido, Cell Chemical Biology, 2022. Read More. Publication. A mass spectrometry-based proteome map of drug action in lung ...

Iván Cornella-Taracido Ph.D. is a Director of Chemical Biology at Merck & Co. Pharmaceuticals in Boston, MA. He is the co-chair of the Phenotypic Screening ...

Feb 9, 2024 · Skilled Biostatistician & Epidemiologist - Mentor, Experienced, Knowledgeable & Passionate Instructor - DoE - Expert in the Analysis of Genomic ...

Ivan Cornella-Taracido's 29 research works with 1327 citations, including: Chemoproteomic profiling to identify activity changes and functional inhibitors ...

Ivan Cornella-Taracido has a strong background in chemical biology and proteomics, with over 20 years of experience in the pharmaceutical industry.

Iván Cornella-Taracido is a Director of Chemical Biology at Merck & Co. Pharmaceuticals (MSD in Europe) in Boston. As co-chair of the Phenotypic Screening ...

Iván Cornella, Company: Covant Therapeutics, Job title: Chief Scientific Officer, Seminars: Chairs, Closing Remarks 5:30 pm.

176 Followers, 33 Following, 1 Posts - Ivan Cornella (@ivancornella) on Instagram: ""